144 related articles for article (PubMed ID: 7519111)
21. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
22. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.
McLoughlin J; Jager R; Abel PD; el Din A; Adam A; Williams G
Br J Urol; 1990 Jul; 66(1):66-70. PubMed ID: 1697492
[TBL] [Abstract][Full Text] [Related]
23. A self-expanding prostatic stent for bladder outlet obstruction in high risk patients.
Morgentaler A; DeWolf WC
J Urol; 1993 Nov; 150(5 Pt 2):1636-40. PubMed ID: 7692101
[TBL] [Abstract][Full Text] [Related]
24. A simple method for insertion of an intraprostatic coil.
Nieben OG; Nordling J; Nielsen KK; Kromann-Andersen B; Absalom MJ; Fowler C
Br J Urol; 1992 Apr; 69(4):381-2. PubMed ID: 1374677
[TBL] [Abstract][Full Text] [Related]
25. Late complications of Prostakath treatment for benign prostatic hypertrophy.
Rosenkilde P; Pedersen JF; Meyhoff HH
Br J Urol; 1991 Oct; 68(4):387-9. PubMed ID: 1718528
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between neurogenic and prostatic obstruction using the intraprostatic spiral. A case report.
Ovesen H; Poulsen AL; Nordling J
Scand J Urol Nephrol; 1990; 24(3):179-80. PubMed ID: 1700470
[TBL] [Abstract][Full Text] [Related]
27. Experience with the Memotherm permanently implanted prostatic stent.
Williams G; White R
Br J Urol; 1995 Sep; 76(3):337-40. PubMed ID: 7551842
[TBL] [Abstract][Full Text] [Related]
28. Self-expandable metallic stents in high-risk patients with benign prostatic hyperplasia: long-term follow-up.
Song HY; Cho KS; Sung KB; Han YM; Kim YG; Kim CS
Radiology; 1995 Jun; 195(3):655-60. PubMed ID: 7538681
[TBL] [Abstract][Full Text] [Related]
29. Prostakath in urinary outflow obstruction.
Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
[TBL] [Abstract][Full Text] [Related]
30. A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapy.
Shore ND; Dineen MK; Saslawsky MJ; Lumerman JH; Corica AP
J Urol; 2007 Mar; 177(3):1040-6. PubMed ID: 17296408
[TBL] [Abstract][Full Text] [Related]
31. Prostatic stents for the treatment of benign prostatic hyperplasia.
Vanderbrink BA; Rastinehad AR; Badlani GH
Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
[TBL] [Abstract][Full Text] [Related]
32. Experience with urethral stent explantation.
Shah DK; Kapoor R; Badlani GH;
J Urol; 2003 Apr; 169(4):1398-400. PubMed ID: 12629371
[TBL] [Abstract][Full Text] [Related]
33. [Experience of a double Malecot polyurethane intraurethral catheter in patients with dysuria].
Okumura A; Muraishi Y; Tsuritani S; Nagakawa O; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1994 May; 40(5):383-6. PubMed ID: 7517619
[TBL] [Abstract][Full Text] [Related]
34. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
35. Role of temporary stents in alternative treatment of benign prostatic hyperplasia.
de la Rosette JJ; Beerlage HP; Debruyne FM
J Endourol; 1997 Dec; 11(6):467-72. PubMed ID: 9440858
[TBL] [Abstract][Full Text] [Related]
36. Treating bladder-outflow obstruction with thermo-expandable prostate metal stents.
Papatsoris AG; El-Husseiny T; Sawada Y; Takahashi T; Nagaoka A; Maan Z; Moraitis K; Masood J; Junaid I; Buchholz N
Expert Rev Med Devices; 2009 Jul; 6(4):357-63. PubMed ID: 19572790
[TBL] [Abstract][Full Text] [Related]
37. Long-term result of Memokath urethral sphincter stent in spinal cord injury patients.
Vaidyanathan S; Soni BM; Oo T; Sett P; Hughes PL; Singh G
BMC Urol; 2002 Nov; 2():12. PubMed ID: 12427256
[TBL] [Abstract][Full Text] [Related]
38. Histological changes associated with long-term urethral stents.
Bailey DM; Foley SJ; McFarlane JP; O'Neil G; Parkinson MC; Shah PJ
Br J Urol; 1998 May; 81(5):745-9. PubMed ID: 9634054
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of urethral stents (Urospiral 2™) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study.
Rouprêt M; Misraï V; de Fourmestraux A; Cour F; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2011 Mar; 30(3):374-9. PubMed ID: 20860015
[TBL] [Abstract][Full Text] [Related]
40. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
